Metabolic research

Cagrilintide 10mg

Late stage

Synthetic amylin analogue

Research material. Not for human or animal consumption.

Research overview

Cagrilintide 10mg is a lyophilised research peptide supplied in a single vial. Cagrilintide is a long-acting synthetic analogue of amylin, a hormone released alongside insulin that is involved in satiety and digestion. It is lipidated to extend its half-life. Cagrilintide has been studied in Phase 3 clinical trials in combination with semaglutide (as CagriSema). A New Drug Application for that combination was submitted to the US FDA in December 2025, and no approval decision had been announced as of September 2026. Cagrilintide is not approved as a medicine on its own anywhere. Store at -20°C away from light, and refrigerate at 2 to 8°C after reconstitution. For research use only. Not for human consumption. Not intended to treat, cure or prevent any disease.

EVIDENCE LEVEL Late stage

Substantial controlled clinical research or late stage development has been identified; this is not a product authorisation claim.

Molecule classSynthetic amylin analogue
Batch documentationAsk for the batch COA
Research fieldMetabolic Research
EnquiriesResearch quotation available

Questions about Cagrilintide 10mg

PRODUCT QUESTIONS
What is Cagrilintide 10mg?

Cagrilintide 10mg is a lyophilised synthetic analogue of amylin supplied in a single vial. Amylin is released alongside insulin and is involved in satiety and digestion. Cagrilintide is lipidated to extend its half life.

What research has been published on Cagrilintide 10mg?

Cagrilintide 10mg contains a peptide studied in Phase 3 clinical trials with semaglutide as CagriSema. A New Drug Application for that combination was submitted to the US FDA in December 2025, with no approval decision announced as of September 2026. Cagrilintide is not approved as a medicine on its own anywhere.

What batch documentation should accompany Cagrilintide 10mg?

Cagrilintide 10mg: Ask for the COA and analytical reports for the batch being quoted. As a lipidated amylin analogue, it should come with intact mass confirming the acylation, HPLC purity with aggregate and deacylated forms reported, and the peptide content of the 10mg vial.

How should Cagrilintide 10mg storage conditions be assessed?

Store Cagrilintide 10mg at −20°C away from light, and refrigerate at 2°C to 8°C after reconstitution. Amylin analogues tend to aggregate, so avoid repeated freeze and thaw cycles and vigorous agitation.

RESEARCH ENQUIRIES

Request a quotation

Enquire about Cagrilintide 10mg and the documentation for the available batch.

Request a quotation
Share record